|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endothelins: pathophysiology and treatment implications in chronic heart failure显示文摘 | Teerlink J R | 2005 | Curt Heart Fail Rep2005，2，4： | 1 |
| 2 | Serelaxin,recombinant human relaxin-2,for treatment of acute heart failure(RELAX-AHF):a randomised,placebo-controlled trial显示文摘 | TEERLINK J R COTTER G DAVISON B A | 2013 | Lancet2013，381，： | 1 |
| 3 | Medical therapy for chronic heart failure 显示文摘 | Krum H Teerlink J R | 2011 | Lancet2011，378，9792： | 1 |
| 4 | Progressive ventricular remodeling in response to diffuse isoproterenol-indueed myocardial necrosis in rats显示文摘 | Teerlink J R Pfeffer J M Pfeffer M A | 1994 | Circ Res1994，75，1： | 1 |
| 5 | The effects of the cardiac myosin activator,omecamtiv mecarbil,on cardiac function in systolic heart failure:a double-blind,placebo-controlled,crossover,dose-ranging phase 2trial显示文摘 | CLELAND?J G TEERLINK J R SENIOR R | 2011 | Lancet2011，378，： | 1 |
| 6 | Pyrrolo- quinoline quinone (PQQ) decreases myocardial infarct size and improves cardiac function in rat models of ische- mia and ischemia/reperfusion 显示文摘 | ZHU B Q ZHOU H Z TEERLINK J R et a} | 2004 | Cardiovascular Drugs and Therapy2004，18，6： | 1 |
| 7 | Progressive ventrieular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats显示文摘 | Teerlink J R Pfeffer J M Pfeffer M A | 1994 | Circ Res1994，75，： | 1 |
| 8 | Relaxin for the treatment of patients with acute heart failure(Pre-RELAXAHF):a multicentr,randomised,placebo-controlled,parallel-group,dose-finding phase IIb study显示文摘 | TEERLINK J R METRA M FELKER G M | 2009 | Lancet2009，373，： | 1 |
| 9 | The clinical significance of asymmetric dimethylarginine显示文摘 | SIROEN M P TEERLINK T NIJVELDT R J | 2006 | Annu Rev Nutr2006，26，： | 1 |
| 10 | Reversal of left ventricular remodeling : role ofthe endothelin pathway 显示文摘 | TEERLINK J R | 2002 | J Card Fail2002，8，6： | 1 |
| 11 | Effects of tezesentan on symptoms and clinical outcomes in patients with acute heart failure:the VERITAS randomized controlled trials显示文摘 | Mcmurray J Teerlink R Cotter G | 2007 | JAMA2007，298，17： | 1 |
| 12 | Progressive ventricular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats显示文摘 | Pfeffer J M Pfeffer M A | 1994 | Circ Res1994，75，1： | 1 |
| 13 | Progressive ventricu- lar remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats 显示文摘 | Teerlink J R Pfeffer J M Pfeffer M A | 1994 | Circ Res1994，75，1： | 1 |
| 14 | Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial 显示文摘 | Teerlink J R Cotter G Davison B A | 2013 | The Lancet2013，381，9860： | 1 |
| 15 | Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction显示文摘 | Bergman M R Teerlink J R Mahimkar R | 2006 | Am J Physiol Heart Circ Physiol2006，292，4： | 1 |
| 16 | Beta-adrenergic blocker mortality trials in congestive heart failure显示文摘 | Massie B M | 1999 | Am J Cardiol1999，84，： | 1 |
| 17 | Tezosentan in patients with acute heart failure:design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS) 显示文摘 | TEERLINK J R McMURRAY J J BOURGE R C | 2005 | Am Heart J2005，150，： | 1 |
| 18 | Pharmacology of new agents for acute heart failure syndromes显示文摘 | Gheorghiade M Teerlink J R Mebazaa A | 2005 | Am J Cardiol2005，96，6： | 1 |
| 19 | Progressive ventrieular remodeling in response to diffuse isoproterenol-induced myocardial necrosis in rats显示文摘 | TEERLINK J R PFEFFER J M PFEFFER M A | 1994 | Cire Res1994，75，： | 1 |
| 20 | A rational approach for the treatment of acute heart failure:current strategies and future options显示文摘 | Sharma M Teerlink J R | 2004 | Curr Opin Cardiol2004，19，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员